Policy Position on U.S. Importation of Prescription Medicines

Published on March 1, 2024

This policy outlines Vital’s opposition to U.S. importation of prescription medicines from Canada, highlighting the risks it poses to domestic supply and existing drug shortages. It emphasizes the need to protect Canada’s drug supply through strong regulation, cross-border collaboration, and ongoing government oversight.